Progress in endoscopic ablation for hepatocellular carcinoma

抄録

In recent years endoscopic surgery has spread worldwide and has been performed widely in the field of liver surgery. Endoscopic surgery for hepatocellular carcinoma (HCC) was adopted in our department in 1994. On the other hand, local ablation therapy has also become established as one of the effective therapies for HCC. However, there is a limit for percutaneous ablation, and overdoing can cause. Endoscopic ablation is used to relieve this condition. Indication for ablation therapy has spread through the increasingly precise use of thoracoscopes and laparoscopes. Furthermore, further ingenuities of endoscopic technique will widen the range of indication as well as improve safety and certainty of ablation therapy.
We encourage a wider application of ablation therapy for use as a treatment strategy for HCC.